Transpharma steroids

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing its proprietary active transdermal drug delivery technology. The company aims to develop multiple drug products through strategic partnerships with leading pharmaceutical companies and through independent product development. TransPharma currently has 3 drug products in clinical trials: ViaDerm-hPTH (1-34) product for the treatment of osteoporosis developed in collaboration with Eli Lilly currently in Phase 2b clinical studies; ViaDerm-GLP1 agonist for the treatment of type II diabetes currently in phase 1b testing and the ViaDerm system combined with an undisclosed peptide currently undergoing phase 1b clinical trials. For more information, please visit the Company's website at -.

Transpharma steroids

transpharma steroids

Media:

transpharma steroids

http://buy-steroids.org